Table 3.
Multivariate analyses of OS among cervical cancer patients based on clinicopathological features and immune scores.
| Characteristics | OS | |
|---|---|---|
| HR (95% CI) | P value | |
| Age (y)a | ||
| ≤40 | 1.000 | |
| 40-50 | 1.285 (0.549,3.006) | 0.563 |
| 50-60 | 0.931 (0.327, 2.653) | 0.894 |
| 60-70 | 1.079 (0.375, 3.103) | 0.888 |
| 70-80 | 5.722 (1.666, 19.647) | 0.006 |
| >80 | - | 0.998 |
| Immune scores | ||
| ≤374.3 | 1.000 | |
| 374.3 to 1051.6 | 0.864 (0.412, 1.811) | 0.699 |
| >1051.6 | 0.305 (0.108, 0.869) | 0.026 |
| Stage | ||
| I | 1.000 | |
| II | 1.418 (0.584, 3.445) | 0.441 |
| III | 1.249 (0.357, 4.364) | 0.728 |
| IV | 5.898 (2.404, 14.473) | 0.0001 |
Abbreviations: CI: confidence interval; aAge at diagnosis of cervical cancer.